# Study of XL418 in Adults With Solid Tumors

> **NCT00460278** · PHASE1 · SUSPENDED · sponsor: **Exelixis** · enrollment: 63 (estimated)

## Conditions studied

- Cancer
- Solid Tumors

## Interventions

- **DRUG:** XL418

## Key facts

- **NCT ID:** NCT00460278
- **Lead sponsor:** Exelixis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 63 (ESTIMATED)
- **Why stopped:** Enrollment suspended due to low drug exposure.
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460278, "Study of XL418 in Adults With Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00460278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*